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INTRODUCTION
Carcinoid tumor, also called neuroendocrine tumor, has a 
potential of progressing to malignancy. In 1907, Oberndorfer
1 
first described ‘karzinoide’ for tumors with the appearance of 
clinically benign course but pathologically closer to malignan-
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cy, and then Gosset and Masson
2 first established the concept of 
endocrine tumor in 1914.
Carcinoid tumors may affect various organs with neuroen-
docrine cells, such as gastrointestinal (GI) tract, bronchus, lung, 
thymus, kidney, ovary and testis, but 75% to 90% of carcinoid 
tumors occur at the GI tract.
3-5 The incidence of GI carcinoid 
tumor is around 2.5 to 5 per 100,000 people, but the incidence 
and prevalence is increasing because of the recent technical im-
provement in endoscopy and radiology.
6 Rectum is the third 
commonly affected lesion of GI carcinoid tumor, following 
small intestine and colon including appendix,
7 and the prev-
alence is reported around 0.05% to 0.07% with endoscopic 
screening.
8 
Rectal carcinoid is found asymptomatic in about 50% of pa-
tients, who are diagnosed early as a small-size asymptomatic 
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carcinoid tumor incidentally by colonoscopy, sigmoidoscopy 
or rectoscopy performed for regular check-up. About 80% of 
typical rectal carcinoid cases are 10 mm or less in size, restrict-
ed in submucosal layer without metastasis, its 5-year survival 
rate estimated around 88.3%,
7 which is why most rectal car-
cinoid cases, with sizes of 10 mm or less, are removed by mini-
mal invasive procedures such as endoscopic or transanal resec-
tion.
9 However, more than 75% of rectal carcinoids are infiltrat-
ed into the submucosal layer, making complete resection with 
polypectomy more difficult,
10 and requiring additional surgical 
interventions in case of incomplete resection. Various endosco-
pic resection methods have been introduced, therefore, to ob-
tain sufficient resection margin including submucosal lesion.
7 
Endoscopic submucosal resection with band ligation (ESMR-
L) ligates tumor with a band and places a snare below the band 
for resection, enabling deep vertical resection margin and high-
er complete resection rate.
11,12 We compared the outcomes of 
treatment between ESMR-L and conventional snare polypec-
tomy, among endoscopic resection methods for 10 mm or less 
rectal carcinoid without metastasis. 
MATERIALS AND METHODS 
Study population
The study was performed in rectal carcinoid cases who re-
ceived endoscopic resection at Busan Paik Hospital and Kosin 
University Gospel Hospital between January 2005 and Septem-
ber 2010. Rectal carcinoids 10 mm or less in size on endoscopy 
and without metastasis on imaging such as abdominal com-
puted tomography (CT) were defined as the indication of en-
doscopic resection. We retrospectively investigated the patients’ 
ages, genders, tumor sizes, locations and malignancy potential 
at diagnosis, as well as the histologic findings, tumor sizes, in-
volvement of the resected margins and mucosal and proper 
muscle invasion of the resected tumors. 
Resection methods
Polypectomy
Tumor was first elevated by submucosal injection of the 
mixed solution (injection fluid) of hypertonic saline, indigo-
carmine and epinephrine diluted to 1:1,000, and then the lesion 
was snared and resected by using electrocautery (Fig. 1). 
ESMR-L
The lesion was elevated by submucosal injection of the same 
injection fluid, and then the distal end of the endoscope was 
equipped with the band ligator (Akita Sumitomo Bakelite Co., 
Ltd., Tokyo, Japan). The tumor was ligated with the band liga-
tor while suctioning, which was then resected by using electro-
cautery with the snare placed below the band (Fig. 2).
Statistical analysis
Student t-test was performed for analysis of patients’ age, tu-
mor sizes and distances from anal verge of each group. Gender, 
Fig. 1. Conventional polypectomy. (A) There is a 6 mm-sized yellow colored submucosal tumor at rectum. (B) Submucosal injection is 
done. (C) Snaring of the elevated submucosal lesion is done. (D) It shows a post-polypectomy ulcer.
A  
C
B
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ratio of positive resection margin (both vertical and lateral), 
mucosal involvement and complication were analyzed using 
Fisher’s exact test; variables affecting complete resection rate 
were validated with multivariate logistic regression method. 
A p-value of less than 0.05 was considered statistically signif-
icant. SPSS version 18.0 for windows (SPSS Inc., Chicago, IL, 
USA) was used for every statistical analysis.
RESULTS
A total of 88 patients, who received endoscopic resection for 
rectal carcinoid, were included in the study. Patients’ age ranged 
from 13 to 72 years; 57 were male and 31 were female patients. 
Tumor size ranged from 2 to 10 mm, and the distance from anal 
verge was 2 to 15 cm. Thirty-three out of the overall patients re-
ceived ESMR-L.
Results of polypectomy and ESMR-L
The rate of positive resection margin was significantly high-
er in the polypectomy group (19/55 [34.5%]) compared to the 
ESMR-L group (2/33 [6.1%], p=0.002), with marked difference 
in vertical resection margin (19/55 [34.5%] and 1/33 [3.0%], re-
Fig. 2. Endoscopic submucosal resection with band ligation. (A) There is a 6 mm-sized yellow colored submucosal mass at rectum. (B) Tu-
mor is aspirated by band ligation cap. (C) Tumor is ligated by band. (D) Snaring of the ligated tumor below band is done.
A  
C
B
D
Table 1. Demographic Characteristics and Endoscopic Findings in Patients with Rectal Carcinoid Resected by Polypectomy and ESMR-L
Endoscopic resection method ESMR-L (n=33) Conventional polypectomy (n=55) p-value
Age, median (range)   55 (37-72) 048 (13-72)  0.009
Male:Female 22:11 35:20  0.821
Size of tumor, mm 6.02±2.36 6.49±3.24  0.474
Distance from anal verge, cm 7.36±3.29 8.11±3.04  0.283
Tumor within 10 cm from anal verge 21 (63.6) 33 (60)0.  0.823
Positive resection margin 2 (6.1) 19 (34.5)  0.002
Positive deep resection margin 1 (3.0) 19 (34.5) <0.001
Positive lateral resection margin 1 (3.0) 3 (5.5)  0.518
Mucosa involvement 18 (54.5) 37 (60.0)  0.262
Immediate bleeding 1 (3.0) 0 (0)0.  0.375
Delayed bleeding 1 (3.0)  0 (0)00  0.375
Values are presented as mean±SD or number (%).
ESMR-L, endoscopic submucosal resection with band ligation.92  Clin Endosc 2012;45:89-94
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spectively, p<0.001). Patients in the ESMR-L group were older 
than those in the polypectomy group, which did not affect the 
study result. Immediate and delayed post-resection bleeding 
was found, 1 case for each, in the ESMR-L group, which was not 
statistically significant. There was no case of perforation in ei-
ther group (Table 1).
Results based on pathologically complete resection
Pathologically complete resection was defined by the existence 
of normal tissues in the mucosa or submucosal layer surround-
ing both vertical and lateral aspects of the tumor without any 
tumor cell in the resection margin on microscopy. Complete re-
section rate was significantly higher when the tumor was nearer 
from the anal verge (p=0.003) and in the ESMR-L group (p= 
0.002) (Table 2). 
Multivariate logistic regression analysis
Variables that could affect the complete resection rate, such 
as age and distance from the anal verge, were analyzed and were 
found significant only in the ESMR-L group with the odds ra-
tio of 0.095 (95% confidence interval, 0.018-0.505; p=0.006) 
(Table 3).
Follow-up
Every patient receiving endoscopic resection went through 
the colonoscopy and abdominal CT, and is currently on the fol-
low-up without the need for an additional intervention.
DISCUSSION
GI carcinoid tumor is a condition with the incidence of 2.5 
to 5 per 100,000 people, and the incidence is ever increasing 
because of the technical improvement in endoscopy and radi-
ology. Modlin et al.
6 reported that the incidence have increased 
4.6 times for small intestine and 7.2 times for the entire GI 
tract, over the past 3 decades. Rectal carcinoid is a rare condi-
tion accounting for only 1.1% to 1.3% of the overall rectal tu-
mor cases.
13,14 Nonetheless, rectum is the third common lesion 
of GI carcinoid tumor,
7 accounting for 36% to 72.3% in South 
Korea, which is higher than 10% to 15% reported in Western 
countries.
15-19 
The two most significant prognostic factors of carcinoid tu-
mor are the tumor size and microinvasion to the proper mus-
cle layer. In large studies, the rate of lymph node metastasis of 
rectal carcinoid was found around 3% to 9.8% when the size was 
10 mm or less, 17% to 81% when 10.1 to 20 mm, and 60% to 
80% when 20 mm or more.
6,7,20-26 About 80% of typical rectal 
carcinoid cases are 10 mm or less in size, restricted in submu-
cosal layer with less metastasis, contributing to its favorable prog-
nosis with 5-year survival rate estimated around 88.3%.
7 For this 
reason, local treatment with endoscopic resection or minimal 
invasive surgery, rather than radical resection, is preferred in 
many cases.
8,9,22,25-28 Rectal carcinoid of 10 mm or less in size, with-
out lymphovascular, proper muscle invasion or lymph node me-
tastasis, is reported to have good prognosis of around 98.9% to 
100% of 5-year survival rate.
6,21,22,29 
Kobayashi et al.
30 reported that tumors of 10 mm or less in size, 
Table 2. Demographic Characteristics and Endoscopic Findings in Patients with Rectal Carcinoid Resected Completely and Incompletely
Histopathologic involvement of resection margin Complete resection (n=67) Incomplete resection (n=21) p-value
Age, median (range)    52 (13-72)  048 (35-72) 0.463
Male:Female 47:20 10:11 0.071
Size of tumor, mm 6.28±2.88 6.44±3.20 0.822
Distance from anal verge, cm 7.28±2.99 9.57±3.01 0.003
Tumor within 10 cm from anal verge 46 (68.7) 08 (38.1) 0.012
ESMR-L 31 (46.3) 2 (9.5) 0.002
Conventional polypectomy 36 (53.7) 19 (90.5) 0.002
Mucosa involvement 40 (59.7) 15 (71.4) 0.441
Immediate bleeding 1 (1.5) 0 (0)0. 0.761
Delayed bleeding 1 (1.5) 0 (0)00 0.761
Values are presented as mean±SD or number (%).
ESMR-L, endoscopic submucosal resection with band ligation.
Table 3. Multivariate Analysis of Risk Factors of Complete Resection
Factor Relative risk 95% CI p-value
Age 1.020 0.973-1.068 0.410
Size of tumor, mm 1.004 0.835-1.208 0.963
Distance from anal verge, cm 1.142 0.634-1.564 0.408
ESMR-L vs. 
  Conventional polypectomy
0.095 0.018-0.505 0.006
CI, confidence interval; ESMR-L, endoscopic submucosal resec-
tion with band ligation.SH Lee et al. 
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without invasion to the proper muscle layer on endoscopic ul-
trasound nor concomitance with tumor retraction or ulcer, are 
completely resectable with polypectomy. It is considered diffi-
cult, however, to achieve pathologically complete resection with 
polypectomy, since 75% of rectal carcinoids are infiltrated into 
the submucosal layer.
10 The complete resection rate of polyp-
ectomy varies from 28.6% to 100%, according to the literature; 
it is commonly known as 64.8% on average,
8,11,31-37 which is 
comparable to the mean 65.5% in this study. Incomplete resec-
tion might cause additional endoscopic or surgical therapy to re-
move remnant tumor, which is why we need a specific thera-
peutic endoscopic procedure that could provide deeper, wider 
resection for removal of submucosal lesion with sufficient resec-
tion margin.
Rectum is fixed to the retroperitoneum, facilitating endos-
copy, and peritonitis is rarely occurred even when the serosa 
was perforated; therefore, options of therapeutic endoscopic 
methods are wider for rectum compared to other organs, includ-
ing strip biopsy,
31,32 suction polypectomy,
34,35 ESMR-L
38,39 and en-
doscopic submucosal dissection
35-37 as the most effective endo-
scopic treatment methods reported for rectal carcinoid. 
ESMR-L provides deeper vertical resection margin, hence 
higher complete resection rate, by suction and band ligation of 
the lesion followed by resection with snare placed below the li-
gated band.
11,12 Complete resection rate of ESMR-L was report-
ed around 95.2% to 100% in the literature
11,12,38,39 and 93.9% in 
this study, which are exceptionally higher than that of conven-
tional polypectomy. Studies by Berkelhammer et al.
38 and Moon 
et al.
39 reported 100% of complete resection rates; but with only 
5 and 11 subjects included, respectively, those results were not 
suitable for generalization. The study by Mashimo et al.
12 was 
performed in a larger population of 63 patients, but was limited 
due to the lack of comparison with polypectomy as well as the 
data on whether the positive resection margins occurred in 3 
patients were vertical or lateral. The study by Ono et al.
11 is 
the only one that performed comparison with polypectomy, 
with more than 10 cases per each group. The present study is 
distinct from the previous studies in including as many cases 
as 33 patients and 55 patients per each group, with more pa-
tients in the control (polypectomy) group. This study also per-
formed analysis on both lateral and vertical resection margins, 
which could provide, through follow-up, a basis for the analy-
sis on the risk of recurrence in the future.
Theoretically, ESMR-L is expected to have higher risk of per-
foration and significant bleeding than polypectomy due to the 
vertically deeper resection. Five patients (7.9%) in the study by 
Mashimo et al.
12 also experienced bleeding requiring endo-
scopic coagulation procedure. Endoscopic submucosal resec-
tion with double ligation technique is reported to be able to 
achieve deep resection margin with reduced complications at the 
same time, by placing a detachable snare below the ligated 
band and resecting in the between of them.
39 We did not use a 
detachable snare in this study, but not a case of perforation oc-
curred, and the one case of each (6.1%) immediate and delayed 
bleeding were mild cases that were controllable with endoscopy 
without a need for surgery for bleeding control or blood trans-
fusion, suggesting that ESMR-L was generally and relatively 
safe.
Ishikawa et al.
40 noted that the lower rectum has significant-
ly thicker internal wall than the upper rectum or colon. The 
wall thickness of the upper rectum is not significantly greater 
than that of the sigmoid colon. The internal wall of the lower 
rectum is supported by the surrounding connective tissues, 
thus it is not perforated by sufficient suction for endoscopic 
resection and enables deeper vertical resection margin. That 
seems to explain why the ESMR-L was superior in complete re-
section rate than conventional polypectomy. The findings of this 
study also suggests that lesions, located in the within 10 cm of 
lower rectum, achieved better complete resection rate by endo-
scopic treatment. 
Cases with positive resection margin, after the endoscopic 
resection of carcinoid tumor, were followed without additional 
treatment, and have been reported not to have a remnant tu-
mor, relapse or metastasis. The heat generated during the re-
section might have destroyed the neighboring remnant tumor 
cells,
8,31,33,40,41 but we should not exclude the possibility that re-
currence or metastasis was not detected in short-term follow-
up due to the slow progression of carcinoid tumor.
19 
This study has several limitations. First, the fact that each of 
the two institutions of this study preferred different endoscopic 
resection methods might have been a confounding factor. The 
results of this study on complete resection rate were similar to 
previous reports, though, suggesting the collected data was ap-
propriate. Second, as the nature of a retrospective study, we could 
not exclude the possibility of selection bias. The possibility seems 
low, however, because the difference of tumor size and location 
between the two groups was not statistically significant, although 
some of the variables were different for each group. The results 
and period of the follow-up, after the endoscopic resection, were 
not specified. Prospective, multi-center studies, with validated 
protocol and longer follow-up period, are warranted.
In conclusion, Small rectal carcinoids, without metastasis, are 
generally treated with endoscopic resection. A specific endo-
scopic resection method is required, however, for conventional 
polypectomy is more likely to cause incomplete resection. ESMR-
L, with deeper resection and easier procedure, is known to be 
effective for small rectal carcinoids. This study also suggested 
that ESMR-L achieved higher complete resection rate than con-
ventional polypectomy, in treating rectal carcinoids of 10 mm 
or less in size. Further prospective multi-center studies, with lon-94  Clin Endosc 2012;45:89-94
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ger follow-up period, are required on this issue.
Conflicts of Interest
The authors have no financial conflicts of interest.
Acknowledgments
This research was supported by Basic Science Research Program through 
the National Research Foundation of Korea (NRF) funded by the Ministry 
of Education, Science and Technology (20100005190).
REFERENCES
1. Oberndorfer S. Karzinoide Tumoren des Dünndarms. Frankf Z Pathol 
1907;1:426-429.
2. Gosset A, Masson P. Tumeurs endocrines de l’appendice. Presse Med 
1914;22:237-240.
3. Marshall JB, Bodnarchuk G. Carcinoid tumors of the gut. Our experi-
ence over three decades and review of the literature. J Clin Gastroen-
terol 1993;16:123-129.
4. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. 
Cancer 1997;79:813-829.
5. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999;340:858-
868.
6. Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuro-
endocrine tumours. Lancet Oncol 2008;9:61-72.
7. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid 
tumors. Cancer 2003;97:934-959.
8. Matsui K, Iwase T, Kitagawa M. Small, polypoid-appearing carcinoid 
tumors of the rectum: clinicopathologic study of 16 cases and effective-
ness of endoscopic treatment. Am J Gastroenterol 1993;88:1949-1953.
9. Okamoto Y, Fujii M, Tateiwa S, et al. Treatment of multiple rectal car-
cinoids by endoscopic mucosal resection using a device for esophageal 
variceal ligation. Endoscopy 2004;36:469-470.
10. Matsumoto T, Iida M, Suekane H, Tominaga M, Yao T, Fujishima M. 
Endoscopic ultrasonography in rectal carcinoid tumors: contribution 
to selection of therapy. Gastrointest Endosc 1991;37:539-542.
11. Ono A, Fujii T, Saito Y, et al. Endoscopic submucosal resection of rec-
tal carcinoid tumors with a ligation device. Gastrointest Endosc 2003;57: 
583-587.
12. Mashimo Y, Matsuda T, Uraoka T, et al. Endoscopic submucosal resec-
tion with a ligation device is an effective and safe treatment for carci-
noid tumors in the lower rectum. J Gastroenterol Hepatol 2008;23:218-
221.
13. Godwin JD 2nd. Carcinoid tumors. An analysis of 2,837 cases. Cancer 
1975;36:560-569.
14. Teleky B, Herbst F, Langle F, Neuhold N, Niederle B. The prognosis of 
rectal carcinoid tumours. Int J Colorectal Dis 1992;7:11-14.
15. Jung KC, Kim HS, Song SY, Choe GY, Kim YI. Carcinoid tumors of 
the gastrointestinal tract: analysis of 36 cases. Korean J Pathol 1996;30:396-
407.
16. Jang NS, Sung KC, Pyeon YJ, et al. Clinical reviews of patients with 
carcinoid tumor. Korean J Gastroenterol 1997;30:179-186.
17. Chung MG, Kang DH, Kim ES, et al. Clinical study of gastrointestinal 
carcinoid tumors. Korean J Gastrointest Endosc 2002;24:135-142.
18. Chang JH, Kim SW, Chung WC, et al. Clinical review of gastrointesti-
nal carcinoid tumor and analysis of the factors predicting metastasis. 
Korean J Gastroenterol 2007;50:19-25.
19. Lee MH, Shin SJ, Jeon SJ, et al. Clinical characteristics of gastrointesti-
nal carcinoid tumors Korean J Gastrointest Endosc 2010;40:347-351.
20. Jetmore AB, Ray JE, Gathright JB Jr, McMullen KM, Hicks TC, 
Timmcke AE. Rectal carcinoids: the most frequent carcinoid tumor. 
Dis Colon Rectum 1992;35:717-725.
21. Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis 
of 1914 reported cases. Cancer 2005;103:1587-1595.
22. Konishi T, Watanabe T, Kishimoto J, Kotake K, Muto T, Nagawa H. 
Prognosis and risk factors of metastasis in colorectal carcinoids: results 
of a nationwide registry over 15 years. Gut 2007;56:863-868.
23. Sauven P, Ridge JA, Quan SH, Sigurdson ER. Anorectal carcinoid tu-
mors. Is aggressive surgery warranted? Ann Surg 1990;211:67-71.
24. Tsukamoto S, Fujita S, Yamaguchi T, et al. Clinicopathological charac-
teristics and prognosis of rectal well-differentiated neuroendocrine tu-
mors. Int J Colorectal Dis 2008;23:1109-1113.
25. Kwaan MR, Goldberg JE, Bleday R. Rectal carcinoid tumors: review of 
results after endoscopic and surgical therapy. Arch Surg 2008;143:471-
475.
26. Ramage JK, Goretzki PE, Manfredi R, et al. Consensus guidelines for 
the management of patients with digestive neuroendocrine tumours: well-
differentiated colon and rectum tumour/carcinoma. Neuroendocrinol-
ogy 2008;87:31-39.
27. Scherübl H. Options for gastroenteropancreatic neuroendocrine tu-
mours. Lancet Oncol 2008;9:203.
28. Shinohara T, Hotta K, Oyama T. Rectal carcinoid tumor, 6 mm in di-
ameter, with lymph node metastases. Endoscopy 2008;40 Suppl 2:E40-
E41.
29. Scherübl H. Rectal carcinoids are on the rise: early detection by screen-
ing endoscopy. Endoscopy 2009;41:162-165.
30. Kobayashi K, Katsumata T, Yoshizawa S, et al. Indications of endo-
scopic polypectomy for rectal carcinoid tumors and clinical usefulness 
of endoscopic ultrasonography. Dis Colon Rectum 2005;48:285-291.
31. Iishi H, Tatsuta M, Yano H, Narahara H, Iseki K, Ishiguro S. More ef-
fective endoscopic resection with a two-channel colonoscope for car-
cinoid tumors of the rectum. Dis Colon Rectum 1996;39:1438-1439.
32. Higaki S, Nishiaki M, Mitani N, Yanai H, Tada M, Okita K. Effective-
ness of local endoscopic resection of rectal carcinoid tumors. Endos-
copy 1997;29:171-175.
33. Koyama N, Yoshida H, Nihei M, Sakonji M, Wachi E. Endoscopic re-
section of rectal carcinoids using double snare polypectomy technique. 
Dig Endosc 1998;10:42-45.
34. Nagai T, Torishima R, Nakashima H, et al. Saline-assisted endoscopic 
resection of rectal carcinoids: cap aspiration method versus simple 
snare resection. Endoscopy 2004;36:202-205.
35. Kim YJ, Lee SK, Cheon JH, et al. Efficacy of endoscopic resection for 
small rectal carcinoid: a retrospective study. Korean J Gastroenterol 
2008;51:174-180.
36. Zhou PH, Yao LQ, Qin XY, et al. Advantages of endoscopic submuco-
sal dissection with needle-knife over endoscopic mucosal resection for 
small rectal carcinoid tumors: a retrospective study. Surg Endosc 2010; 
24:2607-2612.
37. Park HW, Byeon JS, Park YS, et al. Endoscopic submucosal dissection 
for treatment of rectal carcinoid tumors. Gastrointest Endosc 2010;72: 
143-149.
38. Berkelhammer C, Jasper I, Kirvaitis E, Schreiber S, Hamilton J, Wal-
loch J. “Band-snare” resection of small rectal carcinoid tumors. Gas-
trointest Endosc 1999;50:582-585.
39. Moon JH, Kim JH, Park CH, et al. Endoscopic submucosal resection 
with double ligation technique for treatment of small rectal carcinoid 
tumors. Endoscopy 2006;38:511-514.
40. Ishikawa H, Imanishi K, Otani T, Okuda S, Tatsuta M, Ishiguro S. Ef-
fectiveness of endoscopic treatment of carcinoid tumors of the rectum. 
Endoscopy 1989;21:133-135.
41. Koura AN, Giacco GG, Curley SA, Skibber JM, Feig BW, Ellis LM. 
Carcinoid tumors of the rectum: effect of size, histopathology, and sur-
gical treatment on metastasis free survival. Cancer 1997;79:1294-1298.